EP1353916 - PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 27.07.2007 Database last updated on 22.05.2024 | Most recent event Tooltip | 05.10.2007 | Change - lapse in a contracting state State(s) deleted from list of lapses: IT | published on 07.11.2007 [2007/45] | Applicant(s) | For all designated states VERTEX PHARMACEUTICALS INCORPORATED 130 Waverley Street Cambridge, MA 01239-4212 / US | [2006/38] |
Former [2003/43] | For all designated states VERTEX PHARMACEUTICALS INCORPORATED 130 Waverley Street Cambridge, MA 01239-4212 / US | Inventor(s) | 01 /
BEBBINGTON, David 6 Linden Close Newbury, Berkshire R6141QA / GB | 02 /
CHARRIER, Jean-Damien, Vertex Pharmaceuticals Inc. Cottage Wing, Station Rd, Southam Bishops Itchington, Oxfordshire CV47 2QB / GB | 03 /
GOLEC, Julian 8 Manor Farm, Chapel Road Ashbury, Wiltshire SN6 8LS / GB | 04 /
MILLER, Andrew Cherry Cottage Chilton Road Upton Didcot, Oxfordshire OX11 9JL / GB | 05 /
KNEGTEL, Ronald 3 Bath Court, Bath St Abingdom, Oxfordshire OX1X1EE / GB | [2003/43] | Representative(s) | Cornish, Kristina Victoria Joy, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [N/P] |
Former [2003/43] | Cornish, Kristina Victoria Joy, et al Kilburn & Strode, 20 Red Lion Street London WC1R 4PJ / GB | Application number, filing date | 01994323.2 | 19.12.2001 | [2003/43] | WO2001US49401 | Priority number, date | US20000257887P | 21.12.2000 Original published format: US 257887 P | US20010286949P | 27.04.2001 Original published format: US 286949 P | [2003/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO02057259 | Date: | 25.07.2002 | Language: | EN | [2002/30] | Type: | A2 Application without search report | No.: | EP1353916 | Date: | 22.10.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.07.2002 takes the place of the publication of the European patent application. | [2003/43] | Type: | B1 Patent specification | No.: | EP1353916 | Date: | 20.09.2006 | Language: | EN | [2006/38] | Search report(s) | International search report - published on: | EP | 24.04.2003 | Classification | IPC: | C07D403/12, C07D401/14, A61K31/506, A61P35/00 | [2003/43] | CPC: |
C07D403/14 (EP,US);
C07D401/12 (EP,KR,US);
A61P1/00 (EP);
A61P11/06 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P17/06 (EP);
A61P17/14 (EP);
A61P19/02 (EP);
A61P19/08 (EP);
A61P19/10 (EP);
A61P21/00 (EP);
A61P21/02 (EP);
A61P21/04 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/08 (EP);
A61P3/10 (EP);
A61P3/14 (EP);
A61P31/12 (EP);
A61P31/18 (EP);
A61P31/20 (EP);
A61P31/22 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P35/04 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
A61P5/18 (EP);
A61P9/00 (EP);
A61P9/04 (EP);
A61P9/08 (EP);
A61P9/10 (EP);
C07D231/12 (EP,US);
C07D233/56 (EP,US);
C07D249/08 (EP,US);
C07D401/14 (EP,US);
C07D403/12 (EP,US);
C07D405/14 (EP,US);
C07D407/14 (EP,US);
C07D409/14 (EP,US);
C07D417/14 (EP,US);
C07D471/04 (EP,US);
C07D473/16 (EP,US);
C07D487/04 (EP,US);
C07D491/04 (EP,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/43] | Extension states | AL | 17.07.2003 | LT | 17.07.2003 | LV | 17.07.2003 | MK | 17.07.2003 | RO | 17.07.2003 | SI | 17.07.2003 | Title | German: | PYRAZOLVERBINDUNGEN ALS PROTEIN- KINASEHEMMER | [2006/38] | English: | PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS | [2003/43] | French: | COMPOSES DE PYRAZOLE UTILES EN TANT QU'INHIBITEURS DE PROTEINE KINASE | [2003/43] |
Former [2003/43] | PYRAZOLEVERBINDUNGEN ALS PROTEIN- KINASEHEMMER | Entry into regional phase | 17.07.2003 | National basic fee paid | 17.07.2003 | Designation fee(s) paid | 17.07.2003 | Examination fee paid | Examination procedure | 19.07.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 16.07.2003 | Amendment by applicant (claims and/or description) | 17.07.2003 | Examination requested [2003/43] | 29.01.2004 | Despatch of a communication from the examining division (Time limit: M04) | 28.05.2004 | Reply to a communication from the examining division | 24.08.2004 | Despatch of a communication from the examining division (Time limit: M06) | 20.06.2005 | Reply to a communication from the examining division | 18.10.2005 | Communication of intention to grant the patent | 11.04.2006 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 06.06.2006 | Fee for grant paid | 06.06.2006 | Fee for publishing/printing paid | Divisional application(s) | EP06011799.1 / EP1702920 | EP10184271.4 / EP2264028 | Opposition(s) | 21.06.2007 | No opposition filed within time limit [2007/35] | Request for further processing for: | 06.06.2006 | Request for further processing filed | 06.06.2006 | Full payment received (date of receipt of payment) Request granted | 19.07.2006 | Decision despatched | 20.06.2005 | Request for further processing filed | 21.06.2005 | Full payment received (date of receipt of payment) Request granted | 04.07.2005 | Decision despatched | Fees paid | Renewal fee | 12.12.2003 | Renewal fee patent year 03 | 14.12.2004 | Renewal fee patent year 04 | 15.12.2005 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2007/45] |
Former [2007/35] | IT | 20.09.2006 | Cited in | International search | [A]WO0021955 (ZENECA LTD [GB], et al) [A] 1,9* examples 16-20 *; | [A]WO0039101 (ASTRAZENECA UK LTD [GB], et al) [A] 1,9 * examples 135,160,161 * |